ICD-10 Specific code B20.5: HIV disease resulting in other mycoses

Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.

Translations

Language Translation
Flag for English language  English HIV disease resulting in other mycoses
Flag for French language  French Maladie par VIH à l'origine d'autres mycoses

Hierarchical position

Level Code Title
1 I Certain infectious and parasitic diseases
2 B20-B24 Human immunodeficiency virus [HIV] disease
3 B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
4 B20.5 HIV disease resulting in other mycoses

Indicated medicines

Active Ingredient Description
Human normal immunoglobulin G

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. Human normal immunoglobulin contains the IgG antibodies present in the normal population. It is usually prepared from pooled plasma from not fewer than 1000 donors.

Immunoglobulins, normal human, IV

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects.

Minocycline

Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines.